일 지역사회거주 치매의심 노인에서 Apolipoprotein E ${\varepsilon}4$와 인지기능 간의 연관성

문석우,서정석,남범우,최진영,이창훈,박경운,김기웅,Moon, Seok Woo,Seo, Jeong Seok,Nam, Beom Woo,Choi, Jin Young,Lee, Chang Hoon,Park, Kyoung Un,Kim, Ki Woong 대한생물정신의학회 2008 생물정신의학 Vol.15 No.1

Objectives : It was the aim of the present paper to examine the impact of the apolipoprotein E(APOE) ${\varepsilon}4$ on cognitive performance in community-dwelling elderly samples with 'questionable dementia'. Methods : Total 295 samples who were diagnosed with 'questionable dementia' in the recent year and completed the Korean version of the Consortium Establish a Registry for Alzheimer's Disease(CERAD-K) neuropsychological assessment protocol, were recruited. The CDR test established score of 0.5. Genomic DNA was extracted from the venous blood and APOE genotyping was done in this group. Their cognitive performance was compared by the occurrence of the APOE ${\varepsilon}4$ allele. Results : The impact of ${\varepsilon}4$ allele was significant in the Word List Recall Test(WLRT, F=4.511, df=1, p=0.035). The 'young-old' group aged 75 years and under had a significantly lower performance on the Word List Recall Test(WLRT, F=5.090, df=1, p=0.015), but the 'old-old' group over 75 years of age had not significantly different performance on the all the item of tests in ${\varepsilon}4$+ allele group. Conclusion : The conclusion to be drawn here is that community-dwelling elderly samples with ${\varepsilon}4$ allele in 'questionable dementia' had a significantly lower performance on the Word List Recall Test in the CERAD-K neuropsychological test batteries and the effect was prominent in the 'young-old' age group.

Tuberculous Empyema Necessitatis with Osteomyelitis, a Rare Case in the 21^st Century

김한울,임고운,조혜경,이현주,원태희,박경운,김경효,Kim, Han Wool,Lim, Goh-Woon,Cho, Hye Kyung,Lee, Hyunju,Won, Tae Hee,Park, Kyoung Un,Kim, Kyung-Hyo The Korean Society of Pediatric Infectious Disease 2011 Pediatric Infection and Vaccine Vol.18 No.1

흉벽 천공성 농흉(Empyema necessitatis)은 농흉이 흉막 외의 공간으로 확장되어 나간 것을 말한다. 결핵성 흉벽 천공성 농흉은 결핵의 드문 합병증으로서 특히 소아에서는 더욱 드물다. 본 저자들은 결핵에 노출된 병력이 없던 21개월 남자아이에서 7번째 늑골의 골수염에 동반된 결핵성 흉벽천공성 농흉을 경험하여 이에 대해 보고한다. 우리는 환자의 진단과 치료를 위해 수술적 치료를 시행하였고, 조직을 이용한 PCR 및 분자생물학적 검사에서 M. tuberculosis complex를 확인하여 항결핵제를 이용해 합병증 없이 치료하였다. Empyema necessitatis refers to empyema that extends into the extrapleural space through a defect in the pleural surface. Tuberculous empyema necessitatis is a rare complication of tuberculosis. We experienced a 21-month-old boy with tuberculous empyema necessitatis with osteomyelitis in the right $7^{th}$ rib. He presented with a mass on the right lateral chest wall, which was soft and nontender, enlarging for one month. He also had mild fever. The plain radiograph of his chest revealed soft tissue swelling and calcified lymph node on the left axilla, and his PPD skin test was positive. CT scan of the chest showed empyema necessitatis at the right lower chest and upper abdominal walls with osteomyelitis of the right $7^{th}$ rib. He did not have concurrent pulmonary tuberculosis. Surgery was performed for diagnosis and treatment. In histopathologic findings, chronic granulomatous inflammation with caseation necrosis was shown and was positive for acid fast bacilli stain. In addition, M. tuberculosis complex was found as etiology by polymerase chain reaction. The patient has been treated with anti-tuberculous medication without any specific complication.

BioFire^® Meningitis/Encephalitis Panel 의 진단적 유용성 평가: 90일 미만 발열 영아에서의 예비 연구

김경민 ( Kyung Min Kim ),박지영 ( Ji Young Park ),박경운 ( Kyoung Un Park ),손영주 ( Young Joo Sohn ),최윤영 ( Youn Young Choi ),한미선 ( Mi Seon Han ),최은화 ( Eun Hwa Choi ) 대한소아감염학회 2021 Pediatric Infection and Vaccine Vol.28 No.2

목적: 중추신경계 감염의 적절한 치료를 위해서 신속한 원인 병원체의 확인이 중요하다. 본 연구는 열이 있는 영아의 뇌척수액 검체에서 원인 병원체 검출을 위한 BioFire^® Meningitis/Encephalitis (ME) panel 검사 방법의 진단적 가치를 평가하고자 수행되었다. 방법: 2016년 1월부터 2019년 7월까지 발열을 주소로 서울대학교 어린이병원에 내원한 90일 미만의 영아로부터 채취한 뇌척수액으로 기존검사(세균 배양, Xpert^® enterovirus assay, herpes simplex virus-1 and -2 중합효소 연쇄반응 검사)를 시행한 후 -70°C 초저온 냉동고에 보관된 검체를 대상으로 BioFire^® ME panel 검사를 시행하였다. 결과: 총 72개 검체(원인 병원체가 검출된 24개와 검출되지 않은 48개)가 포함되었다. BioFire^® ME panel 검사 결과, 기존검사로 원인 병원체가 검출되지 않은 48개의 검체 중 41개(85.4%)는 음성이었고 원인 병원체가 검출된 24개 검체 중 22개(91.7%)가 동일한 결과(enterovirus 19개, Streptococcus agalactiae 2개, Streptococcus pneumoniae 1개)를 보여 전체 일치율은 87.5% (63/72)였다. 병원체가 기존검사에서 검출되지 않았으나 BioFire^® ME panel에서 검출된 7개의 검체 중 6개에서 human parechovirus (HPeV)가 검출되었다. 결론: 열이 있는 90일 미만 영아에서 BioFire^® ME panel 검사법은 원인 병원체가 밝혀진 기존검사 결과와는 비교적 높은 일치도를 보이며, HPeV를 추가적으로 진단할 수 있었다. 향후, 소아청소년 진료 영역에서 BioFire® ME panel 검사법을 적용할 근거를 마련하기 위한 임상적 유용성과 비용 효과에 대한 연구가 필요하다. Purpose: Rapid detection of etiologic organisms is crucial for initiating appropriate therapy in patients with central nervous system (CNS) infection. This study aimed to evaluate the diagnostic value of the BioFire^® Meningitis/Encephalitis (ME) panel in detecting etiologic organisms in cerebrospinal fluid (CSF) samples from febrile infants. Methods: CSF samples from infants aged <90 days who were evaluated for fever were collected between January 2016 and July 2019 at the Seoul National University Children's Hospital. We performed BioFire^® ME panel testing of CSF samples that had been used for CSF analysis and conventional tests (bacterial culture, Xpert^® enterovirus assay, and herpes simplex virus-1 and -2 polymerase chain reaction) and stored at -70°C until further use. Results: In total, 72 (24 pathogen-identified and 48 pathogen-unidentified) CSF samples were included. Using BioFire^® ME panel testing, 41 (85.4%) of the 48 pathogen-unidentified CSF samples yielded negative results and 22 (91.7%) of the 24 pathogen-identified CSF samples yielded the same results (enterovirus in 19, Streptococcus agalactiae in 2, and Streptococcus pneumoniae in 1) as those obtained using the conventional tests, thereby resulting in an overall agreement of 87.5% (63/72). Six of the 7 pathogen-unidentified samples were positive for human parechovirus (HPeV) via BioFire^® ME panel testing. Conclusions: Compared with the currently available etiologic tests for CNS infection, BioFire^® ME panel testing demonstrated a high agreement score for pathogen-identified samples and enabled HPeV detection in young infants. The clinical utility and cost-effectiveness of BioFire® ME panel testing in children must be evaluated for its wider application.

폐결핵 접촉력을 가진 소아에서 잠복 결핵 감염의 진단을 위한 결핵 특이항원 자극 인터페론-감마 측정의 유용성

성지연 ( Ji Yeon Sung ),김주화 ( Joo Hwa Kim ),양미애 ( Mi Ae Yang ),김소희 ( So Hee Kim ),은병욱 ( Byung Wook Eun ),김남희 ( Nam Hee Kim ),박경운 ( Kyoung Un Park ),이진아 ( Jina Lee ),최은화 ( Eun Hwa Choi ),이환종 ( Hoan Jong L 대한소아감염학회 2008 Pediatric Infection and Vaccine Vol.15 No.1

목 적 : 잠복 결핵 감염 진단 시 사용되는 고전적인 방법인 투베르쿨린 피부 반응 검사(TST) 외 전혈에서 인터페론 감마의 분비능을 측정하는 검사가 개발된 이후 많은 연구들이 그 유용성을 입증하였으나, 소아에서는 그러한 평가가 제한되어 있다. 본 연구는 결핵에 노출된 소아의 잠복 결핵 감염 진단에 있어 QuantiFERON-TB Gold 검사의 유용성을 알아보고자 하였다. 방 법 : 2006년 1월부터 2007년 12월까지 분당 서울 대학교 병원에 결핵 환자와 접촉하여 내원한 소아를 대상으로 흉부 방사선 사진, TST 및 QuantiFERON-TB Gold 검사를 시행하였다. 초기 TST가 음성인 경우, 3개월 뒤 추적 검사를 시행하였다. TST 결과에 따라 초기 TST가 양성인 경우 감염 여부는 확실치 않으나 잠복 감염의 가능성이 있는 군, 초기 TST는 음성이었으나 3개월 뒤 검사에서 양성 전환된 경우는 잠복 결핵 감염군, 처음과 3개월 뒤 TST가 모두 음성인 경우는 감염되지 않은 군으로 정의하였다. 초기 TST가 음성이었으나 추적검사를 하지 않은 경우는 분석에서 제외시켰다. 결 과 : 대상군은 총 49명(남자 22명, 여자 27명) 이었으며, 중앙 연령은 75세(범위; 3개월-14.7세)이었다. QuantiFERON-TB Gold 검사 양성을 보인 소아는 총 5명으로, 감염 여부는 확실치 않으나 잠복 감염의 가능성이 있는 13명 중 3례(23.1%), 잠복 결핵 감염으로 진단된 8명 중 1례(13%), 그리고 감염되지 않은 21명 중 1례(5%)가 포함되었다. QuantiFERON-TB Gold와 TST의 일치도는 0.72이었다(к=0.101). TST와 비교하였을 때 QuantiFERON-TB Gold의 민감도는 12.5%(1/8), 특이도는 95.2%(20/ 21)으로 나타났다. 결 론 : 결핵에 노출된 소아의 잠복결핵감염의 진단에 있어서 QuantiFERON-TB Gold 검사는 TST에 비하여 민감도가 매우 낮아서 임상적 유용성이 불확실하며 더 많은 연구가 필요하다. Purpose : Whole blood interferon-γ assay was developed and many studies showed its usefulness in diagnosing tuberculosis (TB) including latent tuberculosis infection (LTBI). However, assessment in children has been limited. This study was undertaken to evaluate the usefulness of QuantiFERON-TB Gold for the diagnosis of LTBI in children exposed to pulmonary TB. Methods : Children who visited Seoul National University Bundang Hospital with a history of TB exposure were enrolled from January 2006 to December 2007. They were evaluated with chest x-rays, tuberculin skin test (TST) and QuantiFERON-TB Gold test. TST was retested 3 months later for those with initial negative reactivity. Definition of LTBI was made on the basis of the TST reactivity. Results : Among the 103 children with a history of TB exposure, 49 children were tested with chest x-ray, TST, and QuantiFERON-TB Gold. Twenty-two were males. Median age was 7.5 years (range; 3 months to 14.7 years). According to TST reactivity, LTBI was in 8 (19%), no infection was in 21 (50%), possible LTBI was in 13 (31%). QuantiFERON-TB Gold test was positive in 5 of the 49 subjects (10%); 3 of the 13 subjects (23.1%) in unknown status, 1 of the 8 subjects (13%) in LTBI, and 1 of the 21 subjects (5%) without infection. The agreement between the QuantiFERON-TB Gold and the TST was poor (κ=0.101). Conclusion : QuantiFERON-TB Gold showed poor sensitivity for the diagnosis of LTBI in children with exposure to TB. QuantiFERON-TB Gold alone does not seem to be useful in the diagnosis of LTBI in children. (Korean J Pediatr Infect Dis 2008;15:50-57)

증례보고 : 총대동맥활치환술 이후 혈액투석을 받은 환자에서 발생한 헤파린 기인성 혈소판 감소증 -증례보고-

정희진 ( Hee Jin Jeong ),김재광 ( Jae Kwang Kim ),최주연 ( Ju Yeon Choi ),윤승주 ( Seung Zhoo Yoon ),전윤석 ( Yun Seok Jeon ),박경운 ( Kyoung Un Park ),박재현 ( Jae Hyon Bahk ),안혁 ( Hyuk Ahn ),김종성 ( Chong Sung Kim ),김용락 ( 대한마취과학회 2006 Korean Journal of Anesthesiology Vol.50 No.5

Heparin-induced thrombocytopenia (HIT) is an immunologically mediated complication of heparin therapy resulting in the consumption of platelets and a catastrophic thromboembolism. Both the clinical and laboratory features are important for a diagnosis of HIT. There have been 3 case reports of suspected HIT in Korea. However none have satisfied the laboratory features. We experienced a case of HIT, which satisfied both clinical and laboratory features, in a patient who received heparin during continuous veno-venous hemodiafiltration (CVVHD) used to treat acute renal failure that developed after a total aortic arch replacement with a cardiopulmonary bypass. The decreased platelet count and obstruction of extracorporeal filter of CVVHD by the blood clot was observed while receiving unfractionated heparin. The serum from the patient contained the anti heparin-platelet factor 4 antibody, and the condition was thus diagnosed as HIT. Argatroban, which is a direct thrombin inhibitor, was used to treat the thrombosis. (Korean J Anesthesiol 2006; 50: 600~4)

급성 전골수구성 백혈병의 치료 후 추적검사로서 RARa 재배열 소식자를 이용한 분자세포유전학적 검사법의 유용성

박경운,이동순,시차자,고은경,박선양,조한익,한규섭 대한임상병리학회 2001 대한임상병리학회지 Vol.21 No.4

항-Xg^a 항체 1례

박경운,한복연,허미나,안규리,한규섭 大韓輸血學會 2000 大韓輸血學會誌 Vol.11 No.1

반복적인 부비동염으로 내원한 Good 증후군 1예

송경호,김계형,김충종,박경운,전상훈,김홍빈,김남중,오명돈,최강원 대한감염학회 2007 감염과 화학요법 Vol.39 No.5

Good 증후군은 흉선종과 면역결핍이 동반되는 질환으로, B세포의 감소로 인한 범저감마글로불린혈증과 CD4^(+)T세포의 감소로 인한 세포성 면역저하가 동시에 나타나는 것을 특징으로 한다. 본 증례는 18개월 전부터 발생한 반복적인 부비동염을 주소로 내원한 43세 남자 환자로, 내원 1년 전 흉선종절제수술을 시행받았으며, 면역학적 검사상 범저감마글로불린혈증과 T세포의 감소 등의 이상 소견이 발견되었다. 정주 면역글로불린과 경험적 항생제(amoxicillin/clavulanic acid) 사용 후 부비동염이 호전되었으며, 예방접종과 정기적인 면역글로불린 투여 후 특이 합병증없이 경과 관찰 중이다. Good's syndrome is the association of thymoma with immunodeficiency, characterized by hypogammaglobulinemia, B-cell lymphopenia and variably defects in cellular immunity with CD4^(+) T-cell lymphopenia and an inverted CD4^(+):CD8^(+) T-cell ratio. We report a 43-year-old male patient who presented with a 18-month history of productive cough and postnasal drip. One year ago, he underwent the operation for resection of a thymoma. Despite of appropriate management, sinusitis relapsed multiple times. He was found to have hypogammaglobulinemia with nearly absent B cells(4/μL). The CD4^(+) T-cell count was 554/μL with an inverted CD4^(+):CD8^(+) T-cell ratio of 0.6. His symptoms and signs improved with antibiotic treatment and monthly administration of intravenous immunoglobulin (IVIG, 400 mg/kg).

침습성 아스페르길수스증 진단을 위항 갈락토만난 항원검사의 유용성 평가

송경호,이신원,장희창,전재현,박완범,박경운,박상원,오명돈,최강원 대한감염학회 2009 감염과 화학요법 Vol.41 No.2

Background : Invasive aspergillosis (IA) is an important cause of morbidity and mortality among immunocompromised patients. However, 1A is difficult to diagnose, especially in the aforementioned patient group. Recently, galactomannan assay (GMA) using enzyme immunoassay has been introduced in Korea. We evaluated its diagnostic usefulness in the diagnosis of 1A and we analyzed the results according to the underlying diseases. Materials and Methods : All patients who underwent GMA during the period from October 2007 to June 2008 were evaluated retrospectively. According to the criteria of European Organization for Research and Treatment of Cancer/Mycoses Study Group, IA was classified into four clinical categories: proven', probable', possible', and 'non' IA. Patients with 'proven' and 'probable' IA were used as the reference standards for IA. GMA was performed using Platelia Aspergillus EIA (Bio-Rad, Hercules, CA, USA). Optical density index ≥0.5 was considered positive. Results : Of the 144 patients who underwent GMA, two patients were classificed as proven' IA and sixteen patients were probable' 1A. Overall sensitivity, specificity, positive predictive value, and negative predictive value of the assay were 50% (95% confidence interval [C195), 26-74%), 88% (C195, 81-93%), 38% (CI95, 19-59%), and 93% (CI95, 86-97%), respectively. Among the 99 patients with underlying hematologic diseases, GMA showed 67% (C195, 35-90%) sensitivity and 89% (C195, 80-94%) specificity, whereas in 45 patients with underlying diseases other than hematologic diseases, sensitivity and specificity of the assay were 17% (CI95, 0-64%) and 87% (CI95, 73-96%), respectively. Conclusions : GMA showed high specificity, irrespective of the patient population. However, sensitivity of GMA was low and the assay was less sensitive in patients with underlying diseases other than hematologic diseases than in patients with hematologic diseases.

말초혈액조혈모세포채집술 671 예 시행경험

황동희,허미나,박경운,신수,김양현,신희영,안효섭,박선양,한규섭 大韓輸血學會 2000 大韓輸血學會誌 Vol.11 No.2